Stocks and Investing
Stocks and Investing
Wed, January 26, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Whit Mayo Maintained (UNH) at Buy with Increased Target to $550 on, Jan 26th, 2022
Whit Mayo of SVB Leerink, Maintained "UnitedHealth Group Incorporated" (UNH) at Buy with Increased Target from $480 to $550 on, Jan 26th, 2022.
Whit has made no other calls on UNH in the last 4 months.
There are 18 other peers that have a rating on UNH. Out of the 18 peers that are also analyzing UNH, 4 agree with Whit's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matt Borsch of "BMO Capital" Maintained at Hold with Increased Target to $510 on, Friday, January 21st, 2022
- Kevin Caliendo of "UBS" Maintained at Hold with Increased Target to $468 on, Thursday, January 20th, 2022
- Kavin Caliendo of "UBS" Maintained at Hold with Increased Target to $452 on, Wednesday, December 1st, 2021
- David Windley of "Jefferies" Maintained at Hold and Held Target at $440 on, Tuesday, November 30th, 2021
These are the ratings of the 14 analyists that currently disagree with Whit
- John Ransom of "Raymond James" Maintained at Strong Buy with Increased Target to $540 on, Friday, January 21st, 2022
- George Hill of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $482 on, Thursday, January 20th, 2022
- Kevin Fischbeck of "B of A Securities" Maintained at Strong Buy and Held Target at $574 on, Tuesday, January 18th, 2022
- Ben Hendrix of "RBC Capital" Maintained at Buy and Held Target at $563 on, Wednesday, January 12th, 2022
- David Macdonald of "Truist Securities" Maintained at Strong Buy with Increased Target to $575 on, Wednesday, January 5th, 2022
- Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $550 on, Monday, December 20th, 2021
- Lisa Gill of "JP Morgan" Maintained at Buy with Increased Target to $540 on, Friday, December 17th, 2021
- Nathan Rich of "Goldman Sachs" Initiated at Strong Buy and Held Target at $535 on, Tuesday, December 14th, 2021
- Ricky Goldwasser of "Morgan Stanley" Maintained at Buy with Increased Target to $526 on, Wednesday, December 1st, 2021
- Scott Fidel of "Stephens & Co." Maintained at Buy with Increased Target to $475 on, Wednesday, December 1st, 2021
- Stephen Baxter of "Wells Fargo" Maintained at Buy with Increased Target to $520 on, Monday, October 25th, 2021
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Increased Target to $475 on, Friday, October 15th, 2021
- Frank Morgan of "RBC Capital" Maintained at Buy with Increased Target to $476 on, Friday, October 15th, 2021
- Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $495 on, Friday, October 15th, 2021
Contributing Sources